FDA Drugs recall ·

DermaSarra, Camphor 0.5%, External Analgesic, 222 mL (7.5 fl recall

Recall number
D-0165-2026
Date
(initiated August 27, 2025)
Company / brand
DermaRite Industries, LLC
7777 W Side Ave, North Bergen, NJ, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
2,389 bottles
Hazard tags
Microbial contamination Manufacturing practices (cGMP)
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

DermaSarra, Camphor 0.5%, External Analgesic, 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08

Why was it recalled?

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

All lots on or before expiry date 08/2027

Distribution

Nationwide in the USA

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0165-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.